Acquisition allows Pace® to provide full-service regulatory strategy and consulting services to advance FDA submissions across a wide range of therapeutic classes.
Read Press ReleaseThe partnership will bring medically supported virtual cardiac rehabilitation and recovery into the homes of patients in Tampa General's 23-county service area
Read Press ReleaseThe QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) enter a strategic partnership to use artificial intelligence (AI) powered tool for the diagnosis and staging of NASH (non-Alcoholic Steatohepatitis) in patients with type 2 diabetes (T2D).
Read Press ReleaseGb Sciences is focusing considerable resources on bringing its lead Parkinson's disease formulations to the clinic with promising results; plus, new data validating the efficacy of their novel anxiety formulations and demonstrating the improved stability of their oral nanoparticle-encapsulated chronic pain formulations add value to their drug development pipeline.
Read Press ReleaseCharmHealth products now use cutting-edge AI/Image recognition for automated insurance card reading Optical Character Recognition (OCR) to extract patient insurance information from scanned insurance cards, to improve accuracy in insurance claim submissions.
Read Press ReleaseThe Korean biotech company, which has developed a Molecular Diagnostic Tester that detects lung cancer and various cancers at an early stage with a simple breathing test, plans for U.S. clinical trials and FDA registration.
Read Press ReleaseCompass Health Center is launching an Adolescent OCD and Complex Anxiety Disorder Program at its Oak Brook location
Read Press ReleaseMaya will be the outcomes data capture platform for veterans undergoing psychedelic treatments funded by Heroic Hearts Project. Maya will simultaneously be deployed with related organizations, The Mission Within, Heroic Path to Light, and The Hope Project. Combined, this partnership will generate the largest structured dataset illustrating health outcomes of psychedelic treatments for veterans and their family members.
Read Press ReleaseMayo Clinic will onboard Triall's blockchain-integrated eClinical platform to embed verifiable data integrity into a multi-center pulmonary arterial hypertension trial that includes 10 research sites and 500+ patients across the United States.
Read Press ReleaseWhile traditional eye drop bottles require hand-eye coordination and deliver four to five times more medication than the human eye can hold, the Optejet® dispenser's human-centric design administers an easier, more accurate and appropriate dose directly where it is needed in the eye.
Read Press ReleaseThe National Institute of Health awards Cortechs.ai a multimillion grant to quantify microstructural changes in Alzheimer's Disease using Restriction Spectrum Imaging.
Read Press ReleaseNaples, Fla.-based treatment center blends scientifically validated diagnostics and therapies with lifestyle changes for chronic Lyme treatment and therapy for chronic illness.
Read Press Release